Quantcast

News by region

Boehringer Ingelheim doubles funding to 250 M€ for its corporate venture fund

Boehringer Ingelheim today announced an increase in funding for its corporate venture fund, known as the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million.

Posted in Europe, news | Tagged , , | Leave a comment

Premaitha signs new partner to offer NIPT solution in East Asia

Premaitha Health has signed an agreement with a new laboratory partner to offer an NIPT screening solution in a new East Asian territory for Premaitha.  

Posted in Asia, Europe, news, Regions | Leave a comment

FDA accepts sNDA filing for Allergan’s pneumonia drug

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Allergan’s Avycaz (ceftazidime and avibactam) for priority review.

Posted in Approval, news, North America, Regions | Tagged , , , , | Leave a comment

Sanofi appoints new EVP Diabetes & Cardiovascular

Sanofi has appointed Stefan Oelrich as Executive Vice President Diabetes & Cardiovascular (DCV), effectively immediately.

Posted in Europe, news, Regions | Tagged , , | Leave a comment

Novartis’s Alcon introduces new innovations in cataract surgery at ESCRS 2017 annual congress

Alcon, a division of Novartis, will introduce Clareon, the intraocular lens (IOL) with the most advanced optic material available in an automated, disposable, pre-loaded delivery system, at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS) congress taking place October 7 – 11 in Lisbon, Portugal.

Posted in Europe, news, Regions | Tagged , , , | Leave a comment

Eli Lilly in leadership chances

Eli Lilly has made certain leadership changes, promoting several experienced Lilly leaders to executive roles, effective in 2018.

Posted in news, North America, Regions | Tagged , | Leave a comment

FDA OK’s Eli Lilly’s breast cancer drug

The U.S. Food and Drug Administration has approved  Eli Lilly’s Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient’s hormones (endocrine therapy).

Posted in Approval, news, North America, Regions | Tagged , , | Leave a comment

Novartis and UC Berkeley collaborate to tackle ‘undruggable’ disease targets

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered “undruggable.”

Posted in Europe, news, North America, studies | Tagged , , , , | Leave a comment

Basilea Pharmaceutica in license agreement with Chinese drugmaker

Basilea Pharmaceutica has entered into a license agreement with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd. (CR Gosun) for Basilea’s antibiotic Zevtera (ceftobiprole) in China, Hong Kong and Macao (the Territory).

Posted in Asia, news, Regions | Tagged , , | Leave a comment

Novo Nordisk’s diabetes drug in China

China Food and Drug Administration (CFDA) has approved Novo Nordisk’s Tresiba (insulin degludec) for the treatment of diabetes in China.

Posted in Approval, Asia, news, Regions | Tagged , , , | Leave a comment